Newsletter Subject

'It's a Wonderful Thing That We Did Today': What We Heard This Week

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Sun, Feb 19, 2023 11:54 PM

Email Preheader Text

Daily Headlines Sunday, February 19, 2023 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLIGH

[MEDPAGE TODAY]( Daily Headlines Sunday, February 19, 2023 Today's Top Stories for {NAME} [OPINION]( ['It's a Wonderful Thing That We Did Today': What We Heard This Week]( [OPINION]( [Is Your Job on the Chopping Block? Imposter Syndrome a Common Phenomenon]( [MEETING COVERAGE]( [Pembrolizumab Active in BCG-Unresponsive Papillary High-Risk Bladder Cancer]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Novel Approaches for the Treatment of Acute Myeloid Leukemia]( [PODCASTS]( [FDA-Approved Drugs Not Recommended Abroad; RSV Vax for Older Adults]( [OPHTHALMOLOGY]( [FDA Approves First Treatment for Geographic Atrophy Secondary to AMD]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [MEETING COVERAGE]( [Escalated ADT Falls Short in Men With High-Risk Features After Prostatectomy]( CME SPOTLIGHT [Advancing Clinical Decision-Making in Myelofibrosis Care: Focus on Symptom Recognition and Risk Stratification]( [OPINION]( [Cause for Concern: The Stripping Away of Patients' Rights]( [OPINION]( [Six Ways to Make Your Medical Career Worthwhile]( CME SPOTLIGHT [Advancing Post-Transplant CMV Care: Prophylactic and Preemptive Management]( CME SPOTLIGHT [Applying Evidence-Based Clinical Decision-Making to Real-world Patient Cases to Support Safe, Effective, and Adherent Treatment in TNBC]( CME SPOTLIGHT [Immunotherapy in Advanced Melanoma: Evidence-Based Adverse Event Management Strategies to Improve Patient Outcomes]( CME SPOTLIGHT [Individualizing Treatment to Advance Integration of New Evidence and Quality Care in von Willebrand Disease]( # Weekly Survey [Are You Worried About Bird Flu?]( Highly pathogenic avian influenza has been [transmitted to mammals]( and has spread into new countries[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2023-02-19&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/06/2024

Sent On

07/06/2024

Sent On

07/06/2024

Sent On

07/06/2024

Sent On

07/06/2024

Sent On

06/06/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.